| Immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma Y Lin, MP Gustafson, PA Bulur, DA Gastineau, TE Witzig, AB Dietz Blood, The Journal of the American Society of Hematology 117 (3), 872-881, 2011 | 292 | 2011 |
| Pembrolizumab-induced thyroiditis: comprehensive clinical review and insights into underlying involved mechanisms DA Delivanis, MP Gustafson, S Bornschlegl, MM Merten, L Kottschade, ... The Journal of Clinical Endocrinology & Metabolism 102 (8), 2770-2780, 2017 | 290 | 2017 |
| Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties JC Rodrigues, GC Gonzalez, L Zhang, G Ibrahim, JJ Kelly, MP Gustafson, ... Neuro-oncology 12 (4), 351-365, 2010 | 282 | 2010 |
| Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone MP Gustafson, Y Lin, KC New, PA Bulur, BP O'Neill, DA Gastineau, ... Neuro-oncology 12 (7), 631-644, 2010 | 269 | 2010 |
| Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma JC Mertens, CD Fingas, JD Christensen, RL Smoot, SF Bronk, ... Cancer research 73 (2), 897-907, 2013 | 214 | 2013 |
| Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing … ET Camilleri, MP Gustafson, A Dudakovic, SM Riester, CG Garces, ... Stem cell research & therapy 7, 1-16, 2016 | 190 | 2016 |
| The CD14+HLA-DRlo/neg Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy AE Mengos, DA Gastineau, MP Gustafson Frontiers in immunology 10, 1147, 2019 | 147 | 2019 |
| Isoform-and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligase JE Grim, MP Gustafson, RK Hirata, AC Hagar, J Swanger, M Welcker, ... The Journal of cell biology 181 (6), 913-920, 2008 | 143 | 2008 |
| A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans MP Gustafson, Y Lin, ML Maas, VP Van Keulen, PB Johnston, T Peikert, ... PloS one 10 (3), e0121546, 2015 | 136 | 2015 |
| Unanswered questions following reports of secondary malignancies after CAR-T cell therapy BL Levine, MC Pasquini, JE Connolly, DL Porter, MP Gustafson, ... nature medicine 30 (2), 338-341, 2024 | 111 | 2024 |
| A systems biology approach to investigating the influence of exercise and fitness on the composition of leukocytes in peripheral blood MP Gustafson, AC DiCostanzo, CM Wheatley, CH Kim, S Bornschlegl, ... Journal for immunotherapy of cancer 5, 1-14, 2017 | 105 | 2017 |
| IL-10 induces the development of immunosuppressive CD14+ HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma B Xiu, Y Lin, DM Grote, SC Ziesmer, MP Gustafson, ML Maas, Z Zhang, ... Blood cancer journal 5 (7), e328-e328, 2015 | 99 | 2015 |
| Exercise and the immune system: taking steps to improve responses to cancer immunotherapy MP Gustafson, CM Wheatley-Guy, AC Rosenthal, DA Gastineau, ... Journal for immunotherapy of cancer 9 (7), 2021 | 98 | 2021 |
| Folate receptor alpha peptide vaccine generates immunity in breast and ovarian cancer patients KR Kalli, MS Block, PM Kasi, CL Erskine, TJ Hobday, A Dietz, D Padley, ... Clinical Cancer Research 24 (13), 3014-3025, 2018 | 93 | 2018 |
| Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein Y Wang, X Ding, S Wang, CD Moser, HM Shaleh, EA Mohamed, ... Cancer letters 380 (1), 163-173, 2016 | 93 | 2016 |
| Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis MP Gustafson, NP Staff, S Bornschlegl, GW Butler, ML Maas, M Kazamel, ... PloS one 12 (7), e0182002, 2017 | 88 | 2017 |
| Immunosuppressive CD14+HLA-DRlo/neg monocytes are elevated in pancreatic cancer and “primed” by tumor-derived exosomes N Javeed, MP Gustafson, SK Dutta, Y Lin, WR Bamlet, AL Oberg, ... Oncoimmunology 6 (1), e1252013, 2017 | 84 | 2017 |
| Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM)(NCCTG trial N027D) is associated with increased infectious risks JN Sarkaria, E Galanis, W Wu, AB Dietz, TJ Kaufmann, MP Gustafson, ... Clinical Cancer Research 16 (22), 5573-5580, 2010 | 84 | 2010 |
| Association of an increased frequency of CD14+ HLA-DRlo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL) MP Gustafson, RS Abraham, Y Lin, W Wu, DA Gastineau, CS Zent, ... British journal of haematology 156 (5), 674, 2011 | 83 | 2011 |
| Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients MS Block, AB Dietz, MP Gustafson, KR Kalli, CL Erskine, B Youssef, ... Nature communications 11 (1), 5173, 2020 | 80 | 2020 |
Allan B. DietzMayo Clinicmayo.edu의 이메일 확인됨
